Boston Trust Walden Corp cut its stake in Omnicom Group Inc. (NYSE:OMC – Free Report) by 34.8% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 18,021 shares of the business services provider’s stock after selling 9,633 shares during the quarter. Boston Trust Walden Corp’s holdings in Omnicom Group were worth $1,296,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. J2 Capital Management Inc purchased a new position in Omnicom Group in the second quarter worth approximately $383,000. Golden State Wealth Management LLC lifted its stake in shares of Omnicom Group by 230.2% in the 1st quarter. Golden State Wealth Management LLC now owns 492 shares of the business services provider’s stock valued at $41,000 after purchasing an additional 343 shares during the last quarter. Goldman Sachs Group Inc. lifted its stake in shares of Omnicom Group by 42.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,965,974 shares of the business services provider’s stock valued at $245,909,000 after purchasing an additional 887,415 shares during the last quarter. Fifth Third Bancorp lifted its stake in shares of Omnicom Group by 13.9% in the 1st quarter. Fifth Third Bancorp now owns 7,459 shares of the business services provider’s stock valued at $618,000 after purchasing an additional 913 shares during the last quarter. Finally, Oppenheimer & Co. Inc. acquired a new position in shares of Omnicom Group in the 1st quarter valued at $1,357,000. Hedge funds and other institutional investors own 91.97% of the company’s stock.
Omnicom Group Trading Up 0.9%
OMC opened at $79.23 on Thursday. Omnicom Group Inc. has a 12 month low of $68.37 and a 12 month high of $107.00. The stock has a market capitalization of $15.35 billion, a price-to-earnings ratio of 11.37, a PEG ratio of 1.53 and a beta of 0.96. The company has a debt-to-equity ratio of 0.97, a current ratio of 0.92 and a quick ratio of 0.80. The business has a fifty day moving average price of $77.22 and a 200 day moving average price of $74.97.
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on OMC. Weiss Ratings restated a “hold (c)” rating on shares of Omnicom Group in a report on Wednesday, October 8th. Bank of America upgraded shares of Omnicom Group from an “underperform” rating to a “neutral” rating and set a $80.00 price objective on the stock in a report on Monday, June 23rd. Barclays lowered shares of Omnicom Group from an “overweight” rating to an “equal weight” rating and decreased their price objective for the stock from $105.00 to $80.00 in a report on Wednesday, June 25th. Wells Fargo & Company upgraded shares of Omnicom Group from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $78.00 to $91.00 in a report on Tuesday, September 23rd. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Omnicom Group from $104.00 to $96.00 and set an “overweight” rating on the stock in a report on Thursday, July 10th. Five investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $96.29.
Get Our Latest Report on Omnicom Group
Omnicom Group Company Profile
Omnicom Group Inc, together with its subsidiaries, offers advertising, marketing, and corporate communications services. It provides a range of services in the areas of advertising and media, precision marketing, commerce and branding, experiential, execution and support, public relations, and healthcare.
Featured Articles
- Five stocks we like better than Omnicom Group
- How to buy stock: A step-by-step guide for beginners
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- How to Start Investing in Real Estate
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Want to see what other hedge funds are holding OMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omnicom Group Inc. (NYSE:OMC – Free Report).
Receive News & Ratings for Omnicom Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicom Group and related companies with MarketBeat.com's FREE daily email newsletter.